health care, public affairs, government/politics
Toronto
Joined August 2009
- Tweets1.6K
- Following531
- Followers277
- Likes966
Ontarians show strong support for generic medicines sector according to Nanos Research canadianmanufacturing.com/Nb…
1
10
Ontario Welcomes Biosimilar Switching Policy Following Extended Campaign generics.pharmaintelligence.…
11
Ontario’s new drug plan will require a swap of brand-name biologic medications for cheaper versions theglobeandmail.com/canada/a…
15
Cost of Living with Paul Haavardsrud - Nov. 20, 2022: Why is Canada so vulnerable to drug shortages? cbc.ca/listen/live-radio/1-3…
Lobby group urges switch to cheaper, ‘biosimilar’ prescription drugs in Ontario | Globalnews.ca globalnews.ca/news/9187615/o…
1
Why U.S. generic drug manufacturing is shutti... cbsnews.com/video/why-u-s-ge… via @CBSNews
Protecting domestic generic drug manufacturing is vital to national pharmacare plan thestar.com/opinion/contribu… via @torontostar
Canada’s generics industry speaks out on prescription drug access lifehealthpro.ca/news/canada…
Domestic Production Needed For Generics bpmmagazine.com/news/#625000… #Benefits #Pensions #Investment via @pwrshift
Canada's Generic Pharmaceutical Industry Supports Improved Access to Prescription Drug Coverage for Canadians prn.to/37tDHz1
Quebec biosimilars policy could cut drug costs for plan sponsors: expert benefitscanada.com/benefits/…
Canada needs a robust domestic pharmaceutical industry ipolitics.ca/2022/02/25/cana… via @ipoliticsca
Onshoring And Incentives Needed To Protect ‘Fragile’ Industry In Canada generics.pharmaintelligence.…
Generic pharmaceutical association warns of supply chain disruptions insurance-portal.ca/health/g… via @insurancejourn
New Study Calls for Action to Protect Canada's Supply of Prescription Medicines prn.to/3ruGC2b
Switch to biosimilar drugs may save N.S. millions of dollars | CBC News cbc.ca/news/canada/nova-scot…
Generic drug names provide information for doctors, so why is Health Canada promoting the use of pharma brand names? theconversation.com/generic-…